NCT02350868View on ClinicalTrials.gov

Dose-Seeking Study of MPT0E028 in Subjects With Advanced Solid Malignancies Without Standard Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

April 24, 2015

Primary Completion Date

January 19, 2019

Study Completion Date

January 19, 2019

Conditions
Advanced Solid Malignancies
Interventions
DRUG

MPT0E028

The starting dose in the Dose Escalation Phase will be 50 mg/day.Dose escalation from the first cohort to the second cohort will be doubled; and from the second cohort to the fourth cohort will proceed at no more than 50% increments.

Trial Locations (2)

100

National Taiwan University Hospital, Taipei

110

Taipei Medical University Hospital, Taipei

All Listed Sponsors
lead

Taipei Medical University

OTHER

NCT02350868 - Dose-Seeking Study of MPT0E028 in Subjects With Advanced Solid Malignancies Without Standard Treatment | Biotech Hunter | Biotech Hunter